APA

Kajubi R., Huang L., Jagannathan P., Chamankhah N., Were M., Ruel T., Koss C. A., Kakuru A., Mwebaza N., Kamya M., Havlir D., Dorsey G., Rosenthal P. J. & Aweeka F. T. (20170822). Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria Chemoprevention. : Clinical pharmacology and therapeutics.

Chicago

Kajubi R, Huang L, Jagannathan P, Chamankhah N, Were M, Ruel T, Koss C A, Kakuru A, Mwebaza N, Kamya M, Havlir D, Dorsey G, Rosenthal P J and Aweeka F T. 20170822. Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria Chemoprevention. : Clinical pharmacology and therapeutics.

Harvard

Kajubi R., Huang L., Jagannathan P., Chamankhah N., Were M., Ruel T., Koss C. A., Kakuru A., Mwebaza N., Kamya M., Havlir D., Dorsey G., Rosenthal P. J. and Aweeka F. T. (20170822). Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria Chemoprevention. : Clinical pharmacology and therapeutics.

MLA

Kajubi R, Huang L, Jagannathan P, Chamankhah N, Were M, Ruel T, Koss C A, Kakuru A, Mwebaza N, Kamya M, Havlir D, Dorsey G, Rosenthal P J and Aweeka F T. Antiretroviral Therapy With Efavirenz Accentuates Pregnancy-Associated Reduction of Dihydroartemisinin-Piperaquine Exposure During Malaria Chemoprevention. : Clinical pharmacology and therapeutics. 20170822.